drugset / Trial / NCT04342793
A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH
RandomizedParallel-groupDouble-blindTreatment
Summary
The main objective of this study is to evaluate safety and efficacy of ALS-L1023 in patients with Non-alcoholic steatohepatitis
Timeline
- Start
- 2019-12-04
- Primary completion
- 2021-05-11
- Completion
- 2021-05-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALS-L1023 | Unknown | 1200 mg | — |
| Subject | ALS-L1023 | Unknown | 1800 mg | — |